Bruce K.R., Steiger H., Joober R., Ng Ying Kin N. M., Israël M., Young S. N. (2005). Association of the promoter polymorphism -1438G/A of the 5-HT2A receptor gene with behavioral impulsiveness and serotonin function in women with bulimia nervosa, Am J Med Genet B Neuropsychiatr Genet.

Israël M. (2005). What is the role of pharmacotherapy in the treatment of anorexia nervosa?, J Psychiatry Neurosci , 30 (6 ), 464.

Steiger H., Gauvin L., Engelberg M. J., Ying Kin N., Israël M., Wonderlich S. A., Richardson J. (2005). Mood- and restraint-based antecedents to binge episodes in bulimia nervosa: possible influences of the serotonin system, Psychol Med , 35 (11 ), 1553-62.

Steiger H., Joober R., Israël M., Young S. N., Ng Ying Kin N. M., Gauvin L., Bruce K.R., Joncas J., Torkaman-Zehi A. (2005). The 5HTTLPR polymorphism, psychopathologic symptoms, and platelet [(3)H-] paroxetine binding in bulimic syndromes, Int J Eat Disord, 37(1), 57-60.

Steiger H., Richardson J., Israël M., Ng Ying Kin N. M., Bruce K.R., Mansour S., Marie Parent A. (2005). Reduced Density of Platelet-Binding Sites for [3H]Paroxetine in Remitted Bulimic Women, Neuropsychopharmacology, 30(5), 1028-32.